IgA nephropathy is a kidney disorder in which antibodies (called IgA) build up in kidney tissue. Nephropathy is damage, disease, or other problems with the kidney.
IgA nephropathy is also called Berger disease.
Nephropathy - IgA; Berger disease
IgA is a protein, called an antibody, that helps the body fight infections. IgA nephropathy occurs when too much of this protein is deposited in the kidneys. IgA builds up inside the small blood vessels of the kidney. Structures in the kidney called glomeruli become inflamed and damaged.
The disorder can appear suddenly (acute), or get worse slowly over many years (chronic glomerulonephritis).
Risk factors include:
IgA nephropathy can occur in people of all ages, but it most often affects males in their teens to late 30s.
There may be no symptoms for many years.
When there are symptoms, they may include:
IgA nephropathy is most often discovered when a person with no other symptoms of kidney problems has one or more episodes of dark or bloody urine.
There are no specific changes seen during a physical examination. Sometimes, the blood pressure may be high or there may be swelling in parts of the body.
Tests include:
The goal of treatment is to relieve symptoms and prevent or delay chronic renal failure.
The treatment may include:
Salt and fluid intakes may be restricted to control swelling. A low-to-moderate protein diet may be recommended in some cases.
Eventually, many people must be treated for chronic kidney disease and may need dialysis.
IgA nephropathy gets worse slowly. In many cases, it does not get worse at all. Your condition is more likely to get worse if you have:
Contact your health care provider if you have bloody urine or if you are producing less urine than usual.
Floege J, Barratt J, Zhang H. Immunoglobulin A nephropathy and IgA vasculitis (Henoch-Sch�nlein purpura). In: Johnson RJ, Floege J, Tonelli M, eds. Comprehensive Clinical Nephrology. 7th ed. Philadelphia, PA: Elsevier; 2024:chap 24.
Saha MK, Pendergraft WF, Jennette JC, Falk RJ. Primary glomerular disease. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 31.
Review Date:
8/28/2023 Reviewed By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team. |